Truvada and Other HIV Drug Lawsuits
Kidney and bone injuries linked to the HIV drugs Truvada, Viread, Atripla, Complera and Stribild may have been avoided.
Topic Archives: HIV Drugs
-
-
TDF Lawsuit Filed Against Gilead Over Toxic Side Effects of Truvada, Atripla, Other HIV Drugs
In addition to claims filed in federal court, Gilead faces about 24,000 TDF lawsuits in California state court, each raising similar allegations that the drug maker withheld a safer version of its HIV drugs.
-
Lawsuits Over Truvada, Other TDF-Based HIV Drugs Cleared To Move Forward By Appeals Court
California judges determined Truvada lawsuits, Atripla lawsuits, Stribild lawsits, Viread lawsuits and Complera lawsuits can be pursued by users who developed kidney damage, bone fractures and other side effects from the HIV drugs.
-
HIV Drug Descovy May Increase Risk of High Blood Pressure: Study
Researchers warn that the hypertension risks linked to Descovy appear to increase with the age of the patient.
-
Appeals Court Weighs Gilead Challenge to Lawsuits Over Delaying HIV Drug Development
Gilead claims it had no duty to develop safer TAF-based HIV drugs to replace its older TDF-based medications, including Truvada, Viread, Stribild and others, which have been linked to bone fractures, kidney injuries and other side effects.
-
U.S. Task Force Finds “High Benefit” from Use of HIV Drugs for Prevention
Properly identifying patients at higher risk of transmission increases the benefits of prescribing certain HIV drugs as prophylactics, researchers determined.
-
Lawsuit Over Atripla, Truvada Pay-to-Delay Generics Scheme Results in Defense Verdict for Gilead, Teva
This is the third antitrust trial victory for Gilead involving claims it participated in an Atripla and Truvada pay-to-delay generics scheme
-
Lawsuit Against Truvada, Viread Maker Alleges TDF-Based HIV Drugs Toxic to Users Kidneys, Bones
Gilead failed adequately to warn users that its TDF-based HIV drugs could lead to bone demineralization, kidney disease and kidney damage, plaintiffs say.
-
Government’s Gilead HIV Drug Lawsuit Over Patent Rights Ends in Defense Verdict
The Gilead HIV drug lawsuit filed by the Justice Department claimed the drug maker violated patents held by the CDC for the use of Truvada and Descovy as preventative treatments.
-
Gilead Faces Bone Demineralization Lawsuit Over Truvada, Other TDF-Based HIV Drugs
Plaintiffs say they suffered bone demineralization, resulting in bone density loss and permanent injuries due to Gilead's marketing of a less safe formulation of the drugs in order to make more money.
